Hutner Capital Management Inc / ABT
Hutner Capital Management Inc’s Abbott Laboratories Position
Does Hutner Capital Management Inc own Abbott Laboratories (ABT)? Yes — 44.0K shares worth $5M (+1.86% of its 13F portfolio) as of Q1 2026, up from 44.0K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
44.0K
% of Portfolio
+1.86%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 44.0K | $5M | +1.86% |
| Q4 2025 | 44.0K | $6M | +2.30% |
| Q3 2025 | 43.2K | $6M | +2.45% |
| Q2 2025 | 41.5K | $6M | +2.57% |
| Q1 2025 | 41.2K | $5M | +2.34% |
| Q4 2024 | 41.9K | $5M | +2.29% |
| Q3 2024 | 42.0K | $5M | +2.38% |
| Q2 2024 | 42.0K | $4M | +2.39% |
| Q1 2024 | 43.1K | $5M | +2.66% |
| Q4 2023 | 43.2K | $5M | +2.80% |
| Q3 2023 | 43.4K | $4M | +2.58% |
| Q2 2023 | 43.8K | $5M | +2.79% |
| Q1 2023 | 44.8K | $5M | +2.76% |
| Q4 2022 | 44.8K | $5M | +3.05% |
| Q3 2022 | 43.2K | $4M | +2.92% |
| Q2 2022 | 41.9K | $5M | +2.99% |
| Q1 2022 | 41.8K | $5M | +2.82% |
| Q4 2021 | 41.9K | $6M | +3.45% |
| Q3 2021 | 42.0K | $5M | +3.24% |
| Q2 2021 | 42.1K | $5M | +3.13% |
| Q1 2021 | 45.1K | $5M | +3.54% |
| Q4 2020 | 44.4K | $5M | +3.38% |
| Q3 2020 | 44.4K | $5M | +3.59% |
| Q2 2020 | 44.9K | $4M | +3.47% |
| Q1 2020 | 45.0K | $4M | +3.24% |
| Q4 2019 | 45.9K | $4M | +2.75% |
| Q3 2019 | 47.2K | $4M | +2.79% |
| Q2 2019 | 48.0K | $4M | +2.87% |
| Q1 2019 | 48.0K | $4M | +2.81% |
| Q4 2018 | 49.4K | $4M | +2.79% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hutner Capital Management Inc’s full portfolio or all institutional holders of ABT.